Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

Arbyn M, Xu L, Simoens C, Martin-Hirsch PP.

Cochrane Database Syst Rev. 2018 May 9;5:CD009069. doi: 10.1002/14651858.CD009069.pub3. Review.

2.

Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system - Navigation may not be enough.

Dockery LE, Motwani A, Ding K, Doescher M, Dvorak JD, Moore KN, Holman LL.

Gynecol Oncol. 2018 Apr;149(1):89-92. doi: 10.1016/j.ygyno.2017.10.023.

PMID:
29605056
3.

Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact.

Ramey SJ, Asher D, Kwon D, Ahmed AA, Wolfson AH, Yechieli R, Portelance L.

Gynecol Oncol. 2018 Apr;149(1):53-62. doi: 10.1016/j.ygyno.2017.12.010.

PMID:
29605051
4.

An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students.

Staples JN, Wong MS, Rimel BJ.

Gynecol Oncol. 2018 Apr;149(1):101-105. doi: 10.1016/j.ygyno.2017.10.015.

PMID:
29605043
5.

The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.

Beyazit F, Sılan F, Gencer M, Aydin B, Paksoy B, Unsal MA, Ozdemir O.

Ginekol Pol. 2018;89(2):62-67. doi: 10.5603/GP.a2018.0011.

6.

Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study.

Gallotta V, Conte C, Federico A, Vizzielli G, Gueli Alletti S, Tortorella L, Pedone Anchora L, Cosentino F, Chiantera V, Fagotti A, D'Indinosante M, Pelligra S, Scambia G, Ferrandina G.

Eur J Surg Oncol. 2018 Jun;44(6):754-759. doi: 10.1016/j.ejso.2018.01.092. Epub 2018 Feb 13.

PMID:
29422253
7.

Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.

Park SH, Cheon H, Chong GO, Jeong SY, Lee JE, Kang MK, Kim MY, Lee JW, Park J, Kim JC.

Gynecol Oncol. 2018 Mar;148(3):449-455. doi: 10.1016/j.ygyno.2018.01.005. Epub 2018 Jan 10.

PMID:
29329882
8.

Impact of Trainee Involvement in Cervical Excision Procedures: Does Trainee Involvement Impact Quality?

Sullivan SA, Clark LH, West LM, Myrick KS, Tran AQ, Soper JT, Rahangdale L.

J Low Genit Tract Dis. 2018 Jan;22(1):42-46. doi: 10.1097/LGT.0000000000000358.

PMID:
29271856
9.

Lower Incidence of Cervical Intraepithelial Neoplasia among Young Women with Human Papillomavirus Vaccination in Miyagi, Japan.

Ozawa N, Ito K, Tase T, Shibuya D, Metoki H, Yaegashi N.

Tohoku J Exp Med. 2017 Dec;243(4):329-334. doi: 10.1620/tjem.243.329.

10.

Genital Tract Infections in an Isolated Community: 100 Women of the Príncipe Island.

Vieira-Baptista P, Grinceviciene S, Bellen G, Sousa C, Saldanha C, Broeck DV, Bogers JP, Donders G.

Infect Dis Obstet Gynecol. 2017;2017:3058569. doi: 10.1155/2017/3058569. Epub 2017 Nov 13.

11.

Cervical Cancer in the Greater Accra and Ashanti Regions of Ghana.

Nartey Y, Hill PC, Amo-Antwi K, Nyarko KM, Yarney J, Cox B.

J Glob Oncol. 2017 Dec;3(6):782-790. doi: 10.1200/JGO.2016.005744. Epub 2016 Oct 28. Review.

12.

Establishment and analysis of the prediction model for cervical squamous cell carcinoma.

Zhou YH, Fan WF, Deng J, Xi HL.

Eur Rev Med Pharmacol Sci. 2017 Nov;21(22):5042-5048. doi: 10.26355/eurrev_201711_13816.

13.

Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study.

Mahantshetty U, Teni T, Naga P, Hotwani C, Umesh S, Kannan S, Hande V, Pawar S, Engineer R, Chopra S, Deodhar K, Maheshwari A, Gurram L, Gupta S, Shrivastava SK.

Gynecol Oncol. 2018 Feb;148(2):299-304. doi: 10.1016/j.ygyno.2017.11.034. Epub 2017 Dec 6.

PMID:
29203175
14.

Risk prediction model for disease-free survival in women with early-stage cervical cancers following postoperative (chemo)radiotherapy.

Je HU, Han S, Kim YS, Nam JH, Park W, Song S, Song C, Kim JH, Kim J, Yoon WS, Yoon MS, Choi HJ, Kim JY.

Tumori. 2018 Mar-Apr;104(2):105-110. doi: 10.5301/tj.5000697. Epub 2018 May 8.

PMID:
29192739
15.

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.

Polman NJ, Oštrbenk A, Xu L, Snijders PJF, Meijer CJLM, Poljak M, Heideman DAM, Arbyn M.

J Clin Microbiol. 2017 Dec;55(12):3544-3551. doi: 10.1128/JCM.01282-17. Epub 2017 Oct 11.

16.

Quantitative methylation analysis of human papillomavirus 16L1 gene reveals potential biomarker for cervical cancer progression.

Chaiwongkot A, Niruthisard S, Kitkumthorn N, Bhattarakosol P.

Diagn Microbiol Infect Dis. 2017 Dec;89(4):265-270. doi: 10.1016/j.diagmicrobio.2017.08.010. Epub 2017 Aug 25.

PMID:
28985972
17.

Impact of HPV vaccination: health gains in the Italian female population.

Marcellusi A.

Popul Health Metr. 2017 Sep 29;15(1):36. doi: 10.1186/s12963-017-0154-0.

18.

A Narrative Engagement Framework to Understand HPV Vaccination Among Latina and Vietnamese Women in a Planned Parenthood Setting.

Hopfer S, Garcia S, Duong HT, Russo JA, Tanjasiri SP.

Health Educ Behav. 2017 Oct;44(5):738-747. doi: 10.1177/1090198117728761. Epub 2017 Aug 30.

19.

"It Can Promote an Existential Crisis": Factors Influencing Pap Test Acceptability and Utilization Among Transmasculine Individuals.

Peitzmeier SM, Agénor M, Bernstein IM, McDowell M, Alizaga NM, Reisner SL, Pardee DJ, Potter J.

Qual Health Res. 2017 Dec;27(14):2138-2149. doi: 10.1177/1049732317725513. Epub 2017 Aug 24.

PMID:
28836483
20.

Prevalence of High-Risk Genotypes of Human Papillomavirus: Women Diagnosed with Premalignant and Malignant Pap Smear Tests in Southern Ecuador.

Dalgo Aguilar P, Loján González C, Córdova Rodríguez A, Acurio Páez K, Arévalo AP, Bobokova J.

Infect Dis Obstet Gynecol. 2017;2017:8572065. doi: 10.1155/2017/8572065. Epub 2017 Jun 22.

Supplemental Content

Loading ...
Support Center